{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:47:57Z","timestamp":1765820877668,"version":"3.48.0"},"reference-count":19,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,5,11]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary central nervous system lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin\u2019s lymphoma with poor prognosis. 18F-flourodeoxyglucose positron emission tomography (PET)\/magnetic resonance (MR) combines the advantages of PET and MR. The aim of this study is to evaluate the validity of PET\/MR for the diagnosis of PCNSL by means of a meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Wanfang Database, SinoMed, China National Knowledge Infrastructure, the Cochrane Library, PubMed and Embase will be searched for candidate studies about PET\/MRI in PCNSL diagnosis from database inception to October 2024. The following keywords will be applied: \u201cPrimary central nervous system lymphoma\u201d, \u201cPrimary intracerebral lymphoma\u201d, \u201cPositron Emission Tomography Magnetic Resonance\u201d and \u201cPET-MR\u201d. Studies meeting the inclusion criteria will be included. Studies without full true positive, false positive, false negative and true negative values; studies reported in languages other than English and Chinese; conference abstracts not available in full text and case reports will be excluded. Quality Assessment of Diagnostic Accuracy Studies will be used to evaluate the study quality. The STATA software (V.15.0) and Meta-Disc software (V.1.4) will be used to carry out meta-analysis. When heterogeneity is evident, subgroup analysis will be used to investigate the origin of heterogeneity. The robustness of the analysis will be checked with sensitivity analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This research is based on public databases and does not require ethical approval. The results will seek publication in a peer-reviewed journal after the completion of this systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42023472570.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-081458","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T23:07:00Z","timestamp":1716937620000},"page":"e081458","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["18F-FDG PET\/MR for diagnosis of primary central nervous system lymphoma: protocol for a systematic review and meta-analysis"],"prefix":"10.1136","volume":"14","author":[{"given":"Xiaowei","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Radiology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Nursing, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangming","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0197-4426","authenticated-orcid":false,"given":"Bin","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Nursing, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"2025121509431153000_14.5.e081458.1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.108654"},{"key":"2025121509431153000_14.5.e081458.2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30965"},{"key":"2025121509431153000_14.5.e081458.3","first-page":"i1","article-title":"American brain tumor association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"18 Suppl 1","author":"Ostrom","year":"2016","journal-title":"Neuro Oncol"},{"key":"2025121509431153000_14.5.e081458.4","first-page":"2410","article-title":"Primary CNS lymphoma","volume":"35","author":"Grommes","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025121509431153000_14.5.e081458.5","first-page":"15","article-title":"Primary central nervous system lymphoma: a curable disease","volume":"37 Suppl 1","author":"Batchelor","year":"2019","journal-title":"Hematol Oncol"},{"key":"2025121509431153000_14.5.e081458.6","doi-asserted-by":"publisher","DOI":"10.1159\/000495284"},{"key":"2025121509431153000_14.5.e081458.7","first-page":"497","article-title":"Diagnostic performance of pretreatment 18F-fluorodeoxyglucose positron emission tomography with or without computed tomography in patients with primary central nervous system lymphoma: updated systematic review and diagnostic test accuracy meta-analyses","volume":"21","author":"Gupta","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2025121509431153000_14.5.e081458.8","article-title":"Multimodality imaging of primary CNS lymphoma in immunocompetent patients","volume":"87","author":"Partovi","year":"2014","journal-title":"Br J Radiol"},{"key":"2025121509431153000_14.5.e081458.9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28860"},{"key":"2025121509431153000_14.5.e081458.10","first-page":"41518","article-title":"Diagnostic value of using 18F-FDG PET and PET\/CT in immunocompetent patients with primary central nervous system lymphoma: a systematic review and meta-analysis","volume":"8","author":"Zou","year":"2017","journal-title":"Oncotarget"},{"key":"2025121509431153000_14.5.e081458.11","first-page":"6210","article-title":"PET-MR and SPECT-MR multimodality probes: development and challenges","volume":"8","author":"Yang","year":"2018","journal-title":"Theranostics"},{"key":"2025121509431153000_14.5.e081458.12","first-page":"842","article-title":"High-resolution 18F-FDG PET\/MR offers better treatment evaluation than PET\/CT or MRI in CNS lymphoma","volume":"51","author":"Zhang","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"2025121509431153000_14.5.e081458.13","first-page":"322","article-title":"PET\/CT, MR, and PET\/MR in lymphoma and melanoma","volume":"45","author":"Schwenzer","year":"2015","journal-title":"Semin Nucl Med"},{"key":"2025121509431153000_14.5.e081458.14","first-page":"e1","article-title":"Comparison of PET\/MRI with PET\/CT in the evaluation of disease status in lymphoma","volume":"42","author":"Afaq","year":"2017","journal-title":"Clin Nucl Med"},{"key":"2025121509431153000_14.5.e081458.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.19163"},{"key":"2025121509431153000_14.5.e081458.16","unstructured":"Qiu X , Zheng H , Zhong F , et al . 18F-FDG PET\/MR for diagnosis of primary central nervous system lymphoma: protocol for a systematic review and meta-analysis. PROSPERO 2023 CRD42023472570."},{"key":"2025121509431153000_14.5.e081458.17","doi-asserted-by":"publisher","DOI":"10.1059\/0003-4819-155-8-201110180-00009"},{"key":"2025121509431153000_14.5.e081458.18","article-title":"Diagnostic accuracy of the Xpert MTB\/RIF assay for lymph node tuberculosis: a systematic review and meta-analysis","volume":"2019","author":"Yu","year":"2019","journal-title":"Biomed Res Int"},{"key":"2025121509431153000_14.5.e081458.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39500.677199.AE"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-081458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:43:20Z","timestamp":1765820600000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-081458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,28]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/bmjopen-2023-081458"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-081458","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}